Log in

Oxford Immunotec Global SEC Filings & 10K Form (NASDAQ:OXFD)

$16.61
+0.23 (+1.40 %)
(As of 11/16/2019 08:00 AM ET)
Today's Range
$16.28
Now: $16.61
$16.66
50-Day Range
$14.95
MA: $15.83
$17.08
52-Week Range
$11.88
Now: $16.61
$18.60
Volume105,100 shs
Average Volume141,472 shs
Market Capitalization$439.33 million
P/E Ratio32.57
Dividend YieldN/A
Beta0.42

SEC Filings

Oxford Immunotec Global (NASDAQ:OXFD) SEC Filings

DateFilerForm TypeView
11/05/2019
9:01 AM
Oxford Immunotec Global (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2019
6:30 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2019
3:01 PM
Oxford Immunotec Global (Issuer)
Wrighton-Smith Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2019
3:00 PM
Oxford Immunotec Global (Issuer)
Wrighton-Smith Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
3:01 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2019
3:32 PM
Oxford Immunotec Global (Issuer)
Wrighton-Smith Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:53 PM
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Oxford Immunotec Global (Subject)
Form SC 13G
08/06/2019
9:27 AM
Oxford Immunotec Global (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
6:31 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2019
6:43 PM
Oxford Immunotec Global (Issuer)
SANDBERG RICHARD A (Reporting)
Form 4/A
08/05/2019
3:30 PM
Oxford Immunotec Global (Issuer)
SANDBERG RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
3:30 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2019
7:55 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
3:31 PM
Oxford Immunotec Global (Issuer)
Walton Andrew Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
3:31 PM
Oxford Immunotec Global (Issuer)
TOBIN JAMES R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
3:31 PM
Oxford Immunotec Global (Issuer)
SANDBERG RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
3:30 PM
Oxford Immunotec Global (Issuer)
ROSENMAN HERM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
3:30 PM
Oxford Immunotec Global (Issuer)
RANDALL PATRICIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
3:30 PM
Klausner Mark R. (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
3:30 PM
BALTHROP PATRICK J (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
3:30 PM
ANDREWS RONALD ASBURY (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:00 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2019
3:41 PM
Oxford Immunotec Global (Filer)
Form DEFA14A
05/16/2019
3:16 PM
Oxford Immunotec Global (Filer)
Form CT ORDER
05/09/2019
3:09 PM
Oxford Immunotec Global (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
6:30 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
3:33 PM
Oxford Immunotec Global (Filer)
Form DEFA14A
05/03/2019
3:31 PM
Oxford Immunotec Global (Issuer)
SANDBERG RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2019
3:30 PM
Oxford Immunotec Global (Filer)
Form DEF 14A
04/10/2019
3:55 PM
McLaughlin Matthew T E (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2019
3:55 PM
McLaughlin Matthew T E (Reporting)
Oxford Immunotec Global (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2019
3:30 PM
Oxford Immunotec Global (Issuer)
Wrighton-Smith Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
3:30 PM
Linn Stefan C (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2019
4:01 PM
Oxford Immunotec Global (Filer)
Form PRE 14A
03/21/2019
3:20 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2019
3:15 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
4:00 PM
Oxford Immunotec Global (Filer)
Form NT 10-K
03/11/2019
3:16 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2019
3:15 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2019
3:00 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2019
4:15 PM
First Light Asset Management, LLC (Filed by)
Oxford Immunotec Global (Subject)
Form SC 13G/A
03/08/2019
3:30 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2019
3:49 PM
Oxford Immunotec Global (Filer)
Form CT ORDER
03/06/2019
3:30 PM
Keiley Elizabeth M (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
12:25 PM
Alyeska Investment Group, L.P. (Filed by)
Oxford Immunotec Global (Subject)
Form SC 13G/A
02/14/2019
10:14 AM
Consonance Capital Management LP (Filed by)
Oxford Immunotec Global (Subject)
Form SC 13G
02/14/2019
9:17 AM
Oxford Immunotec Global (Subject)
Polar Capital LLP (Filed by)
Form SC 13G/A
02/12/2019
3:14 PM
Flynn James E (Filed by)
Oxford Immunotec Global (Subject)
Form SC 13G/A
02/05/2019
1:42 PM
Invesco Ltd. (Filed by)
Oxford Immunotec Global (Subject)
Form SC 13G/A
02/01/2019
3:30 PM
Oxford Immunotec Global (Issuer)
SANDBERG RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2019
3:35 PM
Oxford Immunotec Global (Issuer)
Wrighton-Smith Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2019
3:35 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2019
3:30 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2019
4:15 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2019
3:45 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2019
5:06 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2019
3:30 PM
Keiley Elizabeth M (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2018
9:19 AM
Oxford Immunotec Global (Filer)
Form CT ORDER
11/09/2018
6:32 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2018
6:28 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2018
6:01 AM
Oxford Immunotec Global (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2018
3:31 PM
First Light Asset Management, LLC (Filed by)
Oxford Immunotec Global (Subject)
Form SC 13G
10/16/2018
7:46 AM
Oxford Immunotec Global (Filer)
Form CT ORDER
10/11/2018
4:30 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2018
3:30 PM
Oxford Immunotec Global (Issuer)
Wrighton-Smith Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
8:55 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2018
4:00 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2018
3:56 PM
Oxford Immunotec Global (Filer)
Form CT ORDER
09/10/2018
3:30 PM
Oxford Immunotec Global (Issuer)
Wrighton-Smith Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2018
8:24 AM
Oxford Immunotec Global (Filer)
Form CT ORDER
08/03/2018
3:30 PM
Oxford Immunotec Global (Issuer)
SANDBERG RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2018
10:08 AM
Oxford Immunotec Global (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2018
6:30 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2018
3:31 PM
Oxford Immunotec Global (Issuer)
Walton Andrew Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
3:31 PM
Oxford Immunotec Global (Issuer)
TOBIN JAMES R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
3:31 PM
Oxford Immunotec Global (Issuer)
SANDBERG RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
3:31 PM
Oxford Immunotec Global (Issuer)
ROSENMAN HERM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
3:30 PM
Oxford Immunotec Global (Issuer)
RANDALL PATRICIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
3:30 PM
Klausner Mark R. (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
3:30 PM
BALTHROP PATRICK J (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
3:30 PM
ANDREWS RONALD ASBURY (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2018
4:20 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2018
3:39 PM
Keiley Elizabeth M (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
3:01 PM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2018
9:08 AM
Oxford Immunotec Global (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2018
6:30 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2018
8:23 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2018
9:39 AM
Oxford Immunotec Global (Filer)
Form CT ORDER
03/19/2018
4:13 PM
Linn Stefan C (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2018
4:13 PM
Altieri Richard M. (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2018
4:12 PM
Oxford Immunotec Global (Issuer)
Wenstrup Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2018
4:12 PM
Oxford Immunotec Global (Issuer)
Wrighton-Smith Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2018
4:12 PM
Keiley Elizabeth M (Reporting)
Oxford Immunotec Global (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2018
9:01 AM
Oxford Immunotec Global (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2018
6:30 AM
Oxford Immunotec Global (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2018
3:30 PM
Oxford Immunotec Global (Issuer)
SANDBERG RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2018
1:30 PM
Alyeska Investment Group, L.P. (Filed by)
Oxford Immunotec Global (Subject)
Form SC 13G
02/14/2018
10:55 AM
Oxford Immunotec Global (Subject)
Polar Capital LLP (Filed by)
Form SC 13G/A
02/12/2018
2:37 PM
Invesco Ltd. (Filed by)
Oxford Immunotec Global (Subject)
Form SC 13G/A
02/01/2018
4:08 PM
Flynn James E (Filed by)
Oxford Immunotec Global (Subject)
Form SC 13G
This page was last updated on 11/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel